Sign up to save your podcasts
Or
Share Estudos WSG-TP-II e MAINTAIN avaliam eficácia da terapia endócrina em diferentes cenários e combinações
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Estudos WSG-TP-II e MAINTAIN avaliam eficácia da terapia endócrina em diferentes cenários e combinações
Referências:
De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/ERBB2-Positive
Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical
Trial. JAMA Oncol. Published online May 11, 2023.
doi:10.1001/jamaoncol.2023.0646 https://jamanetwork.com/journals/jamaoncology/article-abstract/2804892
Y, Tiersten A, Raptis G, Baer LN, Oh SY, Zelnak AB, Wisinski KB, Andreopoulou
E, Gradishar WJ, Stringer-Reasor E, Reid SA, O'Dea A, O'Regan R, Crew KD,
Hershman DL. Randomized Phase II Trial of Endocrine Therapy With or Without
Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in
Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative
Metastatic Breast Cancer: MAINTAIN Trial. J Clin Oncol. 2023 May 19:JCO2202392.
doi: 10.1200/JCO.22.02392. Epub ahead of print. PMID: 37207300. https://ascopubs.org/doi/abs/10.1200/JCO.22.02392
View all episodes
By onconewsReferências:
De-escalated Chemotherapy in Patients with Hormone Receptor–Positive/ERBB2-Positive
Early Breast Cancer: The Neoadjuvant WSG-TP-II Randomized Clinical
Trial. JAMA Oncol. Published online May 11, 2023.
doi:10.1001/jamaoncol.2023.0646 https://jamanetwork.com/journals/jamaoncology/article-abstract/2804892
Y, Tiersten A, Raptis G, Baer LN, Oh SY, Zelnak AB, Wisinski KB, Andreopoulou
E, Gradishar WJ, Stringer-Reasor E, Reid SA, O'Dea A, O'Regan R, Crew KD,
Hershman DL. Randomized Phase II Trial of Endocrine Therapy With or Without
Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in
Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative
Metastatic Breast Cancer: MAINTAIN Trial. J Clin Oncol. 2023 May 19:JCO2202392.
doi: 10.1200/JCO.22.02392. Epub ahead of print. PMID: 37207300. https://ascopubs.org/doi/abs/10.1200/JCO.22.02392